Log in

Relevant bibliographies by topics / Cardiovascular disease risk factors / Journal articles

Journal articles on the topic 'Cardiovascular disease risk factors'

To see the other types of publications on this topic, follow the link: Cardiovascular disease risk factors.

Author: Grafiati

Published: 4 June 2021

Last updated: 10 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Cardiovascular disease risk factors.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Almutairi, Emad Ayidh, Naif Mufleh Alshahrani, Monahi Nasser Alyami, Manal Fnaitel Alanazi, Salwa Fnaitel Alanazi, Mohammad Saeed Abdulrahman Alamri, Abdulmohsen Obaysan Alotaibi, Ohoud Abdulrahman Al-Luhaidan, and Asama Mathkar Alqahtani. "Prevalence of Cardiovascular Disease Risk." International Journal Of Pharmaceutical And Bio-Medical Science 02, no. 12 (December 9, 2022): 592–96. http://dx.doi.org/10.47191/ijpbms/v2-i12-03.

Full text

Abstract:

At the worldwide level, heart disease is the leading cause of death. The primary goals of this study were to look into cardiac risk variables in datasets available on Kaggle. The data included 303 people, 138 of whom had cardiac disease and 165 of whom did not. Age, gender, chest pain, resting blood pressure, cholesterol level, fast blood sugar, electrocardiogram at rest, maximum heart rate during the stress test, angina during exercise, old peak, slope of the ST segment, result of the blood flow observed with radioactive dye, and number of main blood vessels colored by the radioactive dye were all included in the dataset. Descriptive analysis includes means and standard deviations for non-classified variables, as well as frequencies and percentages for categorized variables. The independent T test was used to assess the associations between variables. If 0.05, significance was considered. Except for cholesterol and rapid blood sugar, all of the variables listed above were found to be strongly linked with heart disease. When rapid blood sugar and cholesterol readings are combined, they should be evaluated with caution due to their participation as risk factors for cardiovascular disease.

APA, Harvard, Vancouver, ISO, and other styles

2

Lim, Ming Y., and Rajiv K. Pruthi. "Cardiovascular disease risk factors." Blood Coagulation & Fibrinolysis 22, no. 5 (July 2011): 402–6. http://dx.doi.org/10.1097/mbc.0b013e328345f582.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Williams, Ken, and Howard M. Monroe. "Cardiovascular Disease Risk Prediction Factors." JAMA 308, no. 19 (November 21, 2012): 1969. http://dx.doi.org/10.1001/jama.2012.14042.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Sniderman, Allan D., and Curt D. Furberg. "Cardiovascular Disease Risk Prediction Factors." JAMA 308, no. 19 (November 21, 2012): 1969. http://dx.doi.org/10.1001/jama.2012.14049.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Silva Junior, Delcio G. "Cardiovascular Disorders in Autoimmune Disease." Clinical Cardiology and Cardiovascular Interventions 2, no. 2 (November 12, 2019): 01–04. http://dx.doi.org/10.31579/2641-0419/015.

Full text

Abstract:

The presence of Cardio Vascular Disease (CVD) impacts negatively on expectation and quality of life of the population, being one of the main causes of disability. Many of those who become cardiovascular patients throughout their life could have had different evolution if preventive attitudes were taken. Since 50’s decade, Framingham studies have shown the importance of predetermining factors for CVD occurrence. The classical CVD risk factors such as diabetes, metabolic syndrome, dyslipidemia, hypertension, smoking and family history are well established as predictors of cardiovascular events. The presence of Cardio Vascular Disease (CVD) impacts negatively on expectation and quality of life of the population, being one of the main causes of disability. Many of those who become cardiovascular patients throughout their life could have had different evolution if preventive attitudes were taken. Since 50’s decade, Framingham studies have shown the importance of predetermining factors for CVD occurrence. The classical CVD risk factors such as diabetes, metabolic syndrome, dyslipidemia, hypertension, smoking and family history are well established as predictors of cardiovascular events. However, in certain clinical conditions, traditional risk factors seem not to fully explain the incidence of CVD. Coronary artery disease and early atherosclerosis in young women with Systemic Lupus Erythematosus (SLE) are one of the best examples of how chronic inflammatory diseases can affect individuals who are normally poorly exposed to traditional risk factors. Even with the plurality of extra-articular manifestations of rheumatologic diseases, such as pulmonary hypertension and SLE encephalopathy, uveitis in spondyloarthritis, or as Achalasia in scleroderma, attention is being paid to the frequent cardiovascular system involvement in these patients, especially in the vascular territory

APA, Harvard, Vancouver, ISO, and other styles

6

Young, Laura, and Leslie Cho. "Unique cardiovascular risk factors in women." Heart 105, no. 21 (July 17, 2019): 1656–60. http://dx.doi.org/10.1136/heartjnl-2018-314268.

Full text

Abstract:

Despite an overall reduction in cardiovascular disease (CVD) mortality in the USA, the rate of coronary heart disease and CVD mortality is on the rise in younger women aged 35 to 54 years. This has been attributed to an increasing prevalence of CVD risk factors, which can portend disparate outcomes in women versus men. Women with diabetes and those who smoke have an excess relative risk of CVD when compared with their male counterparts. In addition to these discrepancies in traditional risk factors, a number of clinical conditions unique to women have been shown to increase CVD risks such as pre-eclampsia, gestational diabetes, polycystic ovary syndrome, early menopause and autoimmune diseases. The majority of these sex-specific risk factors can be identified at an early age, allowing for aggressive risk factor modification through lifestyle changes and, in certain patients, medications. The recently published 2018 American College of Cardiology and American Heart Association (ACC/AHA) hypercholesterolaemia and 2019 ACC/AHA primary prevention guidelines reflect this, citing pre-eclampsia, early menopause and autoimmune diseases as ‘risk enhancers’ that if present may favour initiation of statin therapy in borderline or intermediate risk patients. This comprehensive review addresses both traditional and unique risk factors of CVD in women, as well as sex-specific risk stratification and management options.

APA, Harvard, Vancouver, ISO, and other styles

7

Patel, Dr Munna Lal, Rekha Sachan, Dr Radheshyam Dr. Radheshyam, and Dr Pushpalata Sachan. "Cardiovascular risk factors in chronic kidney disease stage-V: A tertiary centre experience." International Journal of Scientific Research 2, no. 12 (June 1, 2012): 81–84. http://dx.doi.org/10.15373/22778179/dec2013/131.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Okereke, Olivia I., and JoAnn E. Manson. "Psychosocial Factors and Cardiovascular Disease Risk." Circulation Research 120, no. 12 (June 9, 2017): 1855–56. http://dx.doi.org/10.1161/circresaha.117.311113.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Licata, Angelo A. "Multiple risk factors in cardiovascular disease." Trends in Endocrinology & Metabolism 4, no. 10 (December 1993): 333. http://dx.doi.org/10.1016/1043-2760(93)90076-q.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Rosendorff, Clive, Michal S. Beeri, and Jeremy M. Silverman. "Cardiovascular Risk Factors for Alzheimer's Disease." American Journal of Geriatric Cardiology 16, no. 3 (March 2007): 143–49. http://dx.doi.org/10.1111/j.1076-7460.2007.06696.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Fedorchenko, R. A., and V. L. Mykhaylenko. "Risk factors of cardiovascular disease nowadays." Journal of Education, Health and Sport 10, no. 4 (April 30, 2020): 243. http://dx.doi.org/10.12775/jehs.2020.10.04.027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Sharabitdinova, Gulshad Gafurkhanovna. "GENETIC RISK FACTORS FOR CARDIOVASCULAR DISEASE." Theoretical & Applied Science 59, no. 03 (March 30, 2018): 240–43. http://dx.doi.org/10.15863/tas.2018.03.59.41.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Herath, HMM. "Novel risk factors in Cardiovascular disease." Galle Medical Journal 11, no. 1 (September 28, 2009): 22. http://dx.doi.org/10.4038/gmj.v11i1.1114.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Connelly, J. "Multiple Risk Factors in Cardiovascular Disease." Journal of Epidemiology & Community Health 48, no. 3 (June 1, 1994): 327. http://dx.doi.org/10.1136/jech.48.3.327.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Connelly, J. "Multiple Risk Factors in Cardiovascular Disease." Journal of Epidemiology & Community Health 48, no. 4 (August 1, 1994): 424. http://dx.doi.org/10.1136/jech.48.4.424-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Luchsinger, José A., and Richard Mayeux. "Cardiovascular risk factors and Alzheimer’s disease." Current Atherosclerosis Reports 6, no. 4 (July 2004): 261–66. http://dx.doi.org/10.1007/s11883-004-0056-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Williams, Redford B., John C. Barefoot, and Neil Schneiderman. "Psychosocial Risk Factors for Cardiovascular Disease." JAMA 290, no. 16 (October 22, 2003): 2190. http://dx.doi.org/10.1001/jama.290.16.2190.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Canto, John G., and Ami E. Iskandrian. "Major Risk Factors for Cardiovascular Disease." JAMA 290, no. 7 (August 20, 2003): 947. http://dx.doi.org/10.1001/jama.290.7.947.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Di Angelantonio, Emanuele, Pei Gao, John Danesh, and for the Emerging Risk Factors Collaboration. "Cardiovascular Disease Risk Prediction Factors—Reply." JAMA 308, no. 19 (November 21, 2012): 1969. http://dx.doi.org/10.1001/jama.2012.14045.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Dahlöf, Björn. "Cardiovascular Disease Risk Factors: Epidemiology and Risk Assessment." American Journal of Cardiology 105, no. 1 (January 2010): 3A—9A. http://dx.doi.org/10.1016/j.amjcard.2009.10.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Lin, Jennifer S., Corinne V. Evans, Eric Johnson, Nadia Redmond, Erin L. Coppola, and Ning Smith. "Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment." JAMA 320, no. 3 (July 17, 2018): 281. http://dx.doi.org/10.1001/jama.2018.4242.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Dülek, Hatice, Zeynep Tuzcular Vural, and Işık Gönenç. "Risk Factors in Cardiovascular Diseases." Journal of Turkish Family Physician 9, no. 2 (June 15, 2018): 53–58. http://dx.doi.org/10.15511/tjtfp.18.00253.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Parikh, Nisha I., Shih-Jen Hwang, Martin G. Larson, James B. Meigs, Daniel Levy, and Caroline S. Fox. "Cardiovascular Disease Risk Factors in Chronic Kidney Disease." Archives of Internal Medicine 166, no. 17 (September 25, 2006): 1884. http://dx.doi.org/10.1001/archinte.166.17.1884.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Hisatome, Ichiro, Peili Li, Fikri Taufiq, Nani Maharani, Masanari Kuwabara, Haruaki Ninomiya, and Udin Bahrudin. "Hyperuricemia as a Risk Factor for Cardiovascular Diseases." Journal of Biomedicine and Translational Research 6, no. 3 (December 23, 2020): 101–9. http://dx.doi.org/10.14710/jbtr.v6i3.9383.

Full text

Abstract:

Serum uric acid level above 7 mg/dl is defined as hyperuricemia, which gives rise to the monosodium urate (MSU), causing gout and urolithiasis. Hyperuricemia is an independent risk factor as well as a marker for hypertension, heart failure, atherosclerosis, atrial fibrillation, and chronic kidney disease. MSU crystals, soluble uric acid (UA), or oxidative stress derived from xanthine oxidoreductase (XOR) might be plausible explanations for the association of cardio-renovascular diseases with hyperuricemia. In macrophages, MSU activates the Nod-like receptor family, pyrin domain containing 3(NLRP3) inflammasome, and proteolytic processing mediated by caspase-1 with enhanced interleukin (IL)-1β and IL-18 secretion. Soluble UA accumulates intracellularly through UA transporters (UAT) in vascular and atrial myocytes, causing endothelial dysfunction ad atrial electrical remodeling. XOR generates reactive oxygen species (ROS) that lead to cardiovascular diseases. Since it remains unclear whether asymptomatic hyperuricemia could be a risk factor for cardiovascular and kidney diseases, European and American guidelines do not recommend pharmacological treatment for asymptomatic patients with cardio-renovascular diseases. The Japanese guideline, on the contrary, recommends pharmacological treatment for hyperuricemia with CKD to protect renal function, and it attaches importance of the cardio-renal interaction for the treatment of asymptomatic hyperuricemia patients with hypertension and heart failure.

APA, Harvard, Vancouver, ISO, and other styles

25

Rao, Aayushee, Sudhanshu Kacker, and Neha Saboo. "The effects of yoga on cardiovascular risk factors." INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 18, no. 7 (November 13, 2022): 396–403. http://dx.doi.org/10.22141/2224-0721.18.7.2022.1214.

Full text

Abstract:

Cardiovascular diseases is a group of disorders of the heart and blood vessels, including coronary heart disease, cerebrovascular disease, rheumatic heart disease, peripheral artery disease, congenital heart disease, deep vein thrombosis, and pulmonary embolism. The most important behavioral risk factors for heart disease and stroke are poor diet, physical inactivity, smoking, and harmful alcohol use. The impact of behavioral risk factors may manifest in each individual as high blood pressure, hyperglycemia, hyperlipidemia, overweight, and obesity. The purpose of this study was to give a thorough scientific analysis of yoga’s contribution to the management and prevention of cardiovascular diseases and related risk factors. The records are collected from several databases. We performed an extensive search of the PubMed/Medline electronic database. However, it is believed that the risk of cardiovascular disease can be reduced by adjusting for several risk factors, such as increasing physical activity and using relaxation to reduce stress, both of which are elements of yoga. As yoga has become an increasingly popular form of exercise, it could be an important intervention for primary and secondary cardiovascular disease prevention. Evidence suggests that regular exercise can reduce the risk of death from cardiovascular disease, and it is beneficial when included in primary and secondary prevention strategies. This review assessed the effectiveness of yoga in reducing various cardiovascular risk factors (blood pressure, weight, body mass index, lipid profile, blood sugar). There is promising evidence that the practice of yoga improves cardiovascular health. Yoga practice length has a beneficial relationship with reducing the risk of сardiovascular diseases. Numerous studies used limited sample numbers, varied the forms and lengths of their yoga treatments, and omitted information on the processes behind change. The prevention and management of cardiovascular illnesses and associated risk factors, however, might be greatly aided by yoga. To even further understand the numerous possible mechanisms behind yoga’s effects, more research is necessary.

APA, Harvard, Vancouver, ISO, and other styles

26

Poole, RM. "Rimonabant reduces risk factors for cardiovascular disease." Inpharma Weekly &NA;, no. 1429 (March 2004): 7–9. http://dx.doi.org/10.2165/00128413-200414290-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Roberts, Cliff, and Maggie Banning. "Risk factors for hypertension and cardiovascular disease." Nursing Standard 12, no. 22 (February 18, 1998): 39–42. http://dx.doi.org/10.7748/ns.12.22.39.s47.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Teramoto, Tamio, Jun Sasaki, Shun Ishibashi, Sadatoshi Birou, Hiroyuki Daida, Seitaro Dohi, Genshi Egusa, et al. "Cardiovascular Disease Risk Factors Other than Dyslipidemia." Journal of Atherosclerosis and Thrombosis 20, no. 10 (2013): 733–42. http://dx.doi.org/10.5551/jat.17368.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Daniels, Stephen R. "Childhood risk factors and adult cardiovascular disease." Journal of Pediatrics 232 (May 2021): 1–3. http://dx.doi.org/10.1016/j.jpeds.2021.03.019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Bøggild, Henrik, and Anders Knutsson. "Shift work, risk factors and cardiovascular disease." Scandinavian Journal of Work, Environment & Health 25, no. 2 (April 1999): 85–99. http://dx.doi.org/10.5271/sjweh.410.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Bashirov, N. H. "MARKERS OF RISK FACTORS FOR CARDIOVASCULAR DISEASE." Eurasian heart journal, no. 3 (September 30, 2020): 78–84. http://dx.doi.org/10.38109/2225-1685-2020-3-78-84.

Full text

Abstract:

Objective: To study the role of risk factors for cardiovascular diseases to optimize their pathogenetic diagnosis.Material and research methods. At the initial stage of clinical trials, all participants (n = 200) were questioned with age-sex characteristics and the main risk factors for cardiovascular diseases (alcohol abuse, smoking, obesity, stress). Biochemical and clinical studies were carried out in two groups of patients, 15 people in each group (the first main group - in addition to bad habits, there is an obesity factor, the second control group - bad habits are detected, but in the absence of obesity) as part of preventive medical examinations.The results of research. When studying psychosocial risk factors for the development of diseases of the cardiovascular system, a higher prevalence rate was noted for men in depression indicators - 26.3% of cases, and in the group of female patients the results were almost 2.5 times lower and amounted to only 15.0%. in both groups of healthy individuals, a low level of the frequency of occurrence of overweight and obesity was observed, compared with the main group, which were diagnosed in 28.6% of cases in the male half of the subjects, and among the representatives of the opposite sex, the indicator was 24.0%. The proportion of obese women in the main and control groups was higher than men by almost 1.5 times. Against the background of obesity and the presence of signs of non-alcoholic fatty degeneration of the liver, in comparison with patients with normal body weight, certain violations were detected in the form of a higher level in the blood of the liver enzyme ALAT - 35.2 ± 1.57 U / L and 21.3 ± 0 95 U / L, respectively, in the first main group and in the second control group.Conclusions. Thus, it was found that the cause of cardiovascular diseases, in particular, cardiac automatism disorders, stroke, myocardial infarction due to metabolic and psychoemotional disorders are overweight and obesity, which worsen the prognosis of CVD, creating the prerequisites for the development of complications.

APA, Harvard, Vancouver, ISO, and other styles

32

Harris, KPG. "Cardiovascular risk factors in progressive renal disease." Clinical Medicine 2, no. 3 (May 1, 2002): 191–94. http://dx.doi.org/10.7861/clinmedicine.2-3-191.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Kaldmäe, Margit, Mihkel Zilmer, Margus Viigimaa, Galina Zemtsovskaja, Karel Tomberg, Tanel Kaart, and Margus Annuk. "Cardiovascular disease risk factors in homeless people." Upsala Journal of Medical Sciences 116, no. 3 (June 22, 2011): 200–207. http://dx.doi.org/10.3109/03009734.2011.586737.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Menon, Vandana, Ambreen Gul, and Mark J. Sarnak. "Cardiovascular risk factors in chronic kidney disease." Kidney International 68, no. 4 (October 2005): 1413–18. http://dx.doi.org/10.1111/j.1523-1755.2005.00551.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Kayyali, Andrea. "Risk Factors for Cardiovascular Disease in Adolescents." AJN, American Journal of Nursing 112, no. 10 (October 2012): 60. http://dx.doi.org/10.1097/01.naj.0000421029.00413.44.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Ueshima, Hirotsugu, Akira Sekikawa, Katsuyuki Miura, Tanvir Chowdhury Turin, Naoyuki Takashima, Yoshikuni Kita, Makoto Watanabe, et al. "Cardiovascular Disease and Risk Factors in Asia." Circulation 118, no. 25 (December 16, 2008): 2702–9. http://dx.doi.org/10.1161/circulationaha.108.790048.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

O'Dea, Kerin. "CARDIOVASCULAR DISEASE RISK FACTORS IN AUSTRALIAN ABORIGINES." Clinical and Experimental Pharmacology and Physiology 18, no. 2 (February 1991): 85–88. http://dx.doi.org/10.1111/j.1440-1681.1991.tb01412.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Oda, Eiji. "Obesity-Related Risk Factors of Cardiovascular Disease." Circulation Journal 73, no. 12 (2009): 2204–5. http://dx.doi.org/10.1253/circj.cj-09-0653.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Won, Jong Uk, Oi Saeng Hong, and Won Ju Hwang. "Actual Cardiovascular Disease Risk and Related Factors." Workplace Health & Safety 61, no. 4 (April 2013): 163–71. http://dx.doi.org/10.1177/216507991306100404.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Barcelo, M. A., M. Saez, and G. C. de Tuero. "Individual Socioeconomic Factors Conditioning Cardiovascular Disease Risk." American Journal of Hypertension 22, no. 10 (October 1, 2009): 1085–95. http://dx.doi.org/10.1038/ajh.2009.146.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Halliday, Anne. "3. Early risk factors for cardiovascular disease." Nutrition Bulletin 15, no. 1 (January 1990): 6–7. http://dx.doi.org/10.1111/j.1467-3010.1990.tb00052.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Schenck-Gustafsson, Karin. "Risk factors for cardiovascular disease in women." Maturitas 63, no. 3 (July 2009): 186–90. http://dx.doi.org/10.1016/j.maturitas.2009.02.014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Ortiz, L. Garcia, I. Santos Rodríguez, P. L. Sánchez Fernández, F. Martin Herrero, Ma C. Mora Santiago, P. L. Sánchez, J. Arganda Maya, and T. Rodriguez Corral. "PRIMORDIAL PREVENTION OF CARDIOVASCULAR DISEASE RISK FACTORS." Journal of Hypertension 18 (June 2000): S178—S179. http://dx.doi.org/10.1097/00004872-200006001-00617.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Purnell, Christianna, Sujuan Gao, Christopher M. Callahan, and Hugh C. Hendrie. "Cardiovascular Risk Factors and Incident Alzheimer Disease." Alzheimer Disease & Associated Disorders 23, no. 1 (January 2009): 1–10. http://dx.doi.org/10.1097/wad.0b013e318187541c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Gill, Sharon K. "Cardiovascular Risk Factors and Disease in Women." Medical Clinics of North America 99, no. 3 (May 2015): 535–52. http://dx.doi.org/10.1016/j.mcna.2015.01.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Pérez-Jiménez, Jara, and Fulgencio Saura-Calixto. "Grape products and cardiovascular disease risk factors." Nutrition Research Reviews 21, no. 2 (December 2008): 158–73. http://dx.doi.org/10.1017/s0954422408125124.

Full text

Abstract:

Many in vivo trials have evaluated the effects of grape products on different CVD risk factors. Most published studies have dealt with some specific aspects of mechanisms of grape flavonoid action or have focused only on one product, such as wine. The aim of the present paper is to review trials dealing with grape products and CVD published during the last 13 years (seventy-five trials). Polyphenols, alcohol and dietary fibre are the main constituents of the tested products. In animal and human studies, grape products have been shown to produce hypotensive, hypolipidaemic and anti-atherosclerotic effects, and also to improve antioxidant status as measured in terms of plasma antioxidant capacity, oxidation biomarkers, antioxidant compounds or antioxidant enzymes. Differences in the design of the studies and in the composition of the tested products (not always provided) could explain the different results of these studies.

APA, Harvard, Vancouver, ISO, and other styles

47

Cannon, Christopher P. "Cardiovascular disease and modifiable cardiometabolic risk factors." Clinical Cornerstone 8, no. 3 (January 2007): 11–28. http://dx.doi.org/10.1016/s1098-3597(07)80025-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Cannon, Christopher P. "Cardiovascular Disease and Modifiable Cardiometabolic Risk Factors." Clinical Cornerstone 9, no. 2 (January 2008): 24–41. http://dx.doi.org/10.1016/s1098-3597(09)62037-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Nangia, R., Harpreet Singh, and Kanwaljit Kaur. "Prevalence of cardiovascular disease (CVD) risk factors." Medical Journal Armed Forces India 72, no. 4 (October 2016): 315–19. http://dx.doi.org/10.1016/j.mjafi.2014.07.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Nash, David T., and Howard Fillit. "Cardiovascular Disease Risk Factors and Cognitive Impairment." American Journal of Cardiology 97, no. 8 (April 2006): 1262–65. http://dx.doi.org/10.1016/j.amjcard.2005.12.031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!